Biotechnology start-up Nuclera has attracted a further $15.5 million in Series B funding, taking its total raised in the round up to $58 million. Much like the initial $42.5 million it raised ea…
Nuclera raises $42.5M towards launch of new protein 3D printer that “makes drug discovery accessible”
Insiders and analysts have made their predictions on the 3D printing trends to watch out for. Find out more in our series focused on the future of 3D printing. Biotechnology start-up Nuclera has …